GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Oriental Bioengineering Inc (OTCPK:AOBI) » Definitions » Change In Receivables

American Oriental Bioengineering (American Oriental Bioengineering) Change In Receivables : $6.0 Mil (TTM As of Sep. 2013)


View and export this data going back to 1991. Start your Free Trial

What is American Oriental Bioengineering Change In Receivables?

American Oriental Bioengineering's change in receivables for the quarter that ended in Sep. 2013 was $1.0 Mil. It means American Oriental Bioengineering's Accounts Receivable declined by $1.0 Mil from Jun. 2013 to Sep. 2013 .

American Oriental Bioengineering's change in receivables for the fiscal year that ended in Dec. 2012 was $-2.6 Mil. It means American Oriental Bioengineering's Accounts Receivable increased by $2.6 Mil from Dec. 2011 to Dec. 2012 .

American Oriental Bioengineering's Accounts Receivable for the quarter that ended in Sep. 2013 was $27.2 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. American Oriental Bioengineering's Days Sales Outstanding for the three months ended in Sep. 2013 was 138.52.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. American Oriental Bioengineering's liquidation value for the three months ended in Sep. 2013 was $-110.0 Mil.


American Oriental Bioengineering Change In Receivables Historical Data

The historical data trend for American Oriental Bioengineering's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Oriental Bioengineering Change In Receivables Chart

American Oriental Bioengineering Annual Data
Trend Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -14.54 -20.11 -23.25 15.79 -2.58

American Oriental Bioengineering Quarterly Data
Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.35 -11.83 11.69 5.15 0.98

American Oriental Bioengineering Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


American Oriental Bioengineering  (OTCPK:AOBI) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

American Oriental Bioengineering's Days Sales Outstanding for the quarter that ended in Sep. 2013 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=27.228/17.936*91
=138.52

2. In Ben Graham's calculation of liquidation value, American Oriental Bioengineering's accounts receivable are only considered to be worth 75% of book value:

American Oriental Bioengineering's liquidation value for the quarter that ended in Sep. 2013 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=3.231-143.949+0.75 * 27.228+0.5 * 20.518
=-110.0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


American Oriental Bioengineering Change In Receivables Related Terms

Thank you for viewing the detailed overview of American Oriental Bioengineering's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


American Oriental Bioengineering (American Oriental Bioengineering) Business Description

Traded in Other Exchanges
N/A
Address
1 Liangshuihe First Ave, Beijing E-Town, Economic and Technology Development Area, E-Town, Beijing, CHN, 100176
Website
American Oriental Bioengineering Inc is a manufacturer of pharmaceutical and healthcare products. Its product line encompasses prescription pharmaceutical products, over-the-counter pharmaceutical products and nutraceutical products.
Executives
Patti Cosimo J director AMERICAN ORIENTAL BIOENGINEERING, INC. 90 PARK AVENUE, 17TH FLOOR NEW YORK NY 10016

American Oriental Bioengineering (American Oriental Bioengineering) Headlines

No Headlines